ViCentra triples manufacturing capacity ahead of Kaleido rollout
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
ViCentra triples manufacturing capacity ahead of Kaleido rollout
Kaleido comes in a range of color options. [Image courtesy of ViCentra]ViCentra announced today that it began commercial-scale production of its Kaleido insulin pump technology at Phillips Medisize. The Dutch automated insulin delivery system developer said it began production of consumables, including infusion sets and insulin cartridges, with the Molex company — a leading global medical technology contract development and manufacturing organiz…
ViCentra Scales Commercial Manufacturing, Triples Capacity and Strengthens Unit Economics
Commercial-scale production of Kaleido consumables begins at contract manufacturer Phillips Medisize Manufacturing capacity more than triples, with initial capacity to support over 17,000 users Volume manufacturing drives gross margin expansion Utrecht, the Netherlands — May 28, 2026 ViCentra, a European medical device company commercializing the Kaleido insulin patch pump system, today announced that commercial‑scale production […] The post ViC…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
